Ryan M. McAdams, MD

He is studying events associated with chorioamnionitis leading to proinflammatory cytokine-induced fetal lung injury that may play a role in the development of bronchopulmonary dysplasia. His future goals include investigating the relationship of the innate immune system and frequently used neurotropic drugs, such as morphine, on neurodevelopment of premature infants. This research will to hopefully identify serum biomarkers associated with poor neurodevelopmental outcomes in stressed neonates treated with sedatives as well as attempt to identify important drug metabolizing enzymes, drug transporters and drug targets to understand interindividual variability in drug clearance and responses in clinical practice. Dr. McAdams is also committed to improving neonatal health in developing countries. He is currently studying gestational age-specific mortality and health care provider attitudes toward newborn viability in a facilities based cohort in Mongolia.